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ABSTRACT 23 
 24 
BACKGROUND 25 
Following ACL injury, ACL reconstruction is an elective procedure and therefore an understanding of the 26 
attributable risk from undergoing ACL reconstruction is necessary for patients to make a fully informed 27 
treatment decision.  28 
PURPOSE 29 
To determine the absolute risk of adverse outcomes including reoperation following ACL reconstruction with 30 
comparison, where possible, to the rate of adverse events reported in the general population. 31 
STUDY DESIGN 32 
Cohort study 33 
METHODS 34 
National hospital data on all ACL reconstructions performed in England between April 1, 1997 and March 31, 35 
2017 were analysed. Revision cases, bilateral procedures within 6 months, and cases with concurrent cartilage 36 
or multiple ligament surgery were excluded. The primary outcome was the occurrence of at least one serious 37 
complication (myocardial infarction, stroke, pulmonary embolism, infection requiring surgery, fasciotomy, 38 
neurovascular injury, or death) within 90-days. Additionally, 5-year rates of revision ACL reconstruction, 39 
contralateral reconstruction, and meniscal surgery were investigated. 40 
RESULTS 41 
133,270 ACL reconstructions were performed of which 104,255 were eligible for analysis. Within 90 days, 42 
serious complications occurred in 675 (0.65%; 95% confidence interval [CI] 0.60-0.70), including 494 43 
reoperations for infection (0.47%; 95% CI 0.43-0.52) and 129 pulmonary embolisms (0.12%; 95% CI 0.10-44 
0.15). Of 54,275 patients with at least 5 years follow-up, 1746 (3.22%; 95% CI 3.07-3.37) underwent revision 45 
ACL reconstruction in the same knee, 1553 contralateral ACL reconstruction (2.86%; 95% CI 2.72-3.01), and 46 
340 (0.63%; 0.56-0.70) subsequent meniscal surgery. The overall risk of serious complications fell over time 47 
(adjusted odds ratio [OR] 0.96 per year; 95% CI 0.95-0.98) however older patients (adjusted OR 1.11 per 5-48 
years; 95% CI 1.07-1.16) and patients with a greater modified Charlson comorbidity index (adjusted OR 2.41 49 
per 10-units; 95% CI 1.65-3.51) were are higher risk. For every 850 (95% CI 720-1039) ACL reconstructions 50 
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done, one pulmonary embolism could be provoked. For every 213 (95% CI 195-233), one native knee joint 51 
infection could be provoked. 52 
CONCLUSION 53 
The overall risk of adverse events following ACL reconstruction is low, however some rare but serious 54 
complications, including infection or pulmonary embolism, may occur. Around 3% of patients undergo a 55 
further same side or opposite side ACL reconstruction within five years. These data will inform shared 56 
decision making between clinicians and patients considering their treatment options. 57 
 58 
What is known about this subject 59 
• Before this study, several systematic reviews have attempted to estimate the risk of adverse events 60 
after ACL reconstruction however the findings have been limited by small numbers of studies, small 61 
number of patients, non-representative data sources, and concerns about incomplete data capture.  62 
• For infection rates, a systematic review of level 2 studies published in 2017 reported a 0.43% deep 63 
infection rate (58/13401; 95% CI 0.32 to 0.56). For pulmonary embolism, a systematic review of 47 64 
included studies published in 2016 reported a rate of 0.14% (1/704; 95% CI 0.00 to 0.79). A rate of 65 
revision ACL reconstruction of 3.59% (587/16336; 95% CI 3.31 to 3.89) was reported from a large 66 
military health database series in 2016. A systematic review published in 2015 previously estimated a 67 
12.5% (335/2682) risk of contralateral ACL injury.  68 
 69 
What this study adds to existing knowledge 70 
• ACL reconstruction was associated with a 0.65% risk of serious complications within 90 days 71 
(pulmonary embolism, infection requiring surgery, myocardial infarction, stroke, fasciotomy, 72 
neurovascular injury, death).  73 
• Using comparative general population data, it was determined that for every 850 fewer ACL 74 
reconstructions performed, one pulmonary embolism and four native knee joint infections could be 75 
provoked.  76 
• Within 5-years, 3.2% patients require revision ACL reconstruction in the same knee, 0.63% undergo 77 
meniscal surgery in the same knee, and 2.9% undergo ACL reconstruction in the opposite knee. 78 
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Women are at lower risk of revision surgery and meniscal surgery but not opposite side 79 
reconstruction, in comparison to men. 80 
• Although the risk of adverse events after ACL reconstruction is greater than after arthroscopic partial 81 
meniscectomy, the overall risk from this type of surgery remains low.  82 
• Nevertheless, as ACL reconstruction may be an avoidable intervention for many people following 83 
ACL injury, this new understanding of risk and reoperation rates is crucial for patients to be able to 84 
make an informed treatment decision.  85 
  86 
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INTRODUCTION 87 
 88 
The incidence of anterior cruciate ligament (ACL) injury in the population is approximately 0.03% 89 
per year, rising to over 3% in studies of certain professional athletes.26 Reconstruction of the ACL is 90 
frequently recommended due to functional impairment and concerns about the development of 91 
meniscal or articular cartilage damage from recurrent instability of the knee.15,35 The population rate 92 
of ACL reconstruction ranges from approximately 8 to 52/100,000 people between countries;5,26  in 93 
England, the intervention rate was 24/100,000 in 2016-17.2  94 
 95 
In 2010, a clinical trial indicated that for many patients with an ACL injury, a strategy of 96 
rehabilitation with optional delayed ACL reconstruction may avoid the need for surgery.16 Other 97 
groups, however, continue to advocate early reconstruction due the risks of cartilage and meniscal 98 
damage from recurrent knee instability.11,14,16,19,25 As ACL reconstruction is an elective procedure, 99 
besides the anticipated benefits of undergoing the procedure, it is crucially important for patients and 100 
clinicians to have knowledge of the specific risks.6 Before this study, several studies have attempted 101 
to estimate the risk of adverse events after ACL reconstruction.4,13,21,22,24,32–34 The findings, however, 102 
have generally been limited by small numbers of studies, small number of patients, non-103 
representative data sources, and concerns about incomplete data capture. 104 
 105 
The purpose of this study was to determine the risks of adverse outcomes following anterior cruciate 106 
ligament reconstruction within 90-days of surgery, with comparison, where possible, to the rate of 107 
adverse events reported in the general population. The secondary aim was to examine the risk of 108 
subsequent ipsilateral and contralateral ACL reconstruction within 5-years. 109 
 110 
  111 
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METHODS 112 
 113 
Data source 114 
National Hospital Episode Statistics (HES) data was obtained from NHS Digital (application DARS-115 
NIC-68703) and linked with the Office for National Statistics (ONS) mortality dataset. HES contains 116 
a record of all patient attendances at NHS hospitals in England, covering episodes of care delivered 117 
in treatment centres (including those in the independent sectors) funded by the NHS, episodes of care 118 
in England where patients are resident outside of England, and privately funded patients treated 119 
within NHS England hospitals.28 The information recorded in the HES database includes patient 120 
demographic and residence data, primary and secondary diagnoses including comorbidities, and all 121 
procedures undertaken. The ONS mortality dataset contains national death certificate data, 122 
irrespective of whether the death occurred in hospital or in the community.  123 
 124 
Procedures 125 
All HES records between 1 April 1997 and 31 March 2017 were extracted for patients undergoing 126 
ACL reconstruction. Episodes were identified from the Classification of Surgical Operations and 127 
Procedures (OPCS-4) codes in the procedure fields within the HES data (W742 [excluding repair or 128 
synthetic graft procedures W841, W842, W723, W724]).29 Simultaneous or staged (within 6 months) 129 
bilateral cases were excluded along with cases with concurrent articular cartilage or multiple 130 
ligament surgery. Per patient, per side, only the first (primary) ACL procedure was included as an 131 
index procedure. For each patient identified as undergoing an index ACL reconstruction, all the 132 
patient’s prior and subsequent hospital episodes were identified for the entire data extraction period. 133 
Subsequent revision procedures in the same patient were not eligible for analysis as index procedures 134 
but were analysed as reoperation outcomes (see Outcomes, below). Cases missing essential data 135 
(age, sex, procedure date, procedure laterality) were excluded from the study. Cases missing non-136 
essential data (index of multiple deprivation, ethnicity, rurality) were included except for analyses 137 
adjusting for these specific variables. 138 
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 139 
Outcomes 140 
Complications were identified by a review of a combination of the twenty International Statistical 141 
Classification of Diseases and Related Health Problems (ICD-10) diagnosis fields per hospital 142 
episode and twenty-four OPCS operation fields per episode.29,39 Complications identified from the 143 
ICD-10 diagnosis fields were as follows: pulmonary embolism (PE), myocardial infarction, stroke, 144 
lower respiratory tract infection, acute kidney injury, urinary tract infection, and neurovascular 145 
injury. Complications identified from the OPCS operation codes were confirmed to match with the 146 
laterality (left versus right) of the index procedure using the OPCS laterality codes. The procedure-147 
based complications were as follows: joint infection, fasciotomy, general reoperation (any surgical 148 
procedure performed in the same knee within 90 days), revision ACL reconstruction, meniscal 149 
surgery, contralateral ACL reconstruction. Mortality data was extracted from the ONS mortality 150 
fields. The primary outcome was the occurrence of at least one serious complication within 90-days 151 
of an index ACL reconstruction. A serious complication was defined as either myocardial infarction, 152 
stroke, pulmonary embolism, infection requiring surgery (open or arthroscopic irrigation and lavage 153 
or debridement [excluding haemarthrosis]), fasciotomy, neurovascular injury, or death. The rate of 154 
each individual complication was then evaluated secondarily, with each complication counted 155 
whether in isolation of in combination with other adverse outcomes. The secondary outcomes were 156 
revision ACL reconstruction procedures, subsequent meniscal surgery procedures in the same knee, 157 
and contralateral knee ACL reconstruction procedures within 5-years. 158 
 159 
Statistical analysis 160 
Stata v15.1 (StataCorp, College Station, Texas, USA) was used to perform all analysis. Descriptive 161 
statistics were used to report demographic data. Complication rates were reported with confidence 162 
intervals corresponding to the proportion of the study sample. Logistic regression methods were used 163 
to first calculate the unadjusted odds of each complication occurring within 90-days by age, sex, 164 
index of multiple deprivation (quintile derived from regional factors in England including average 165 
  8 
income, employment, education, housing, and crime; 1=least deprived area, 5=most deprived),30 166 
ethnicity, modified Charlson comorbidity index (Summary Hospital-level Mortality Indicator 167 
Specification; derived with a maximum 5-year ICD-10 diagnosis code lookback period),7,20,41 year of 168 
treatment, ethnicity, and rurality. The odds ratios were then adjusted including all these variables in 169 
the same statistical model. Cox proportional hazards modelling, adjusted in the same manner, was 170 
used to identify associations with same side revision ACL reconstruction, contralateral ACL 171 
reconstruction, and same side meniscal surgery. Long-term rates of revision ACL reconstruction 172 
were also assessed using a mortality adjusted Kaplan-Meier survival analysis (not undergoing 173 
revision surgery). 174 
 175 
In order to guide patients and clinicians regarding the relative risk of undergoing the procedure, age-176 
sex matched general population study data was reviewed where available in published data. 177 
Population and adverse event numbers were extracted from the ONS national mortality report and 178 
from publications reporting population rates of myocardial infarction, pulmonary embolus, stroke, 179 
and septic arthritis respectively.10,12,17,36,38 Annualised rates were adjusted directly to estimate 90-day 180 
complication rates. The relative risk (risk ratio) of adverse events was calculated, where possible, by 181 
comparing the adverse event rate in an age-sex matched sample of patients in the general population. 182 
The number needed to harm (NNH) was calculated from the risk difference between the study cohort 183 
and the general population data (attributable risk).  184 
 185 
Role of the funding source 186 
The sponsors of the study had no role in the design or conduct of the study. All authors take 187 
responsibility for the contents of the study and the decision to proceed to publication.   188 
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RESULTS 189 
 190 
Between 1 April 1997 and 31 March 2017, 133 270 ACL reconstructions (124 489 patients) were 191 
identified of which 104 255 (102 309 patients) were included (Figure 1). The mean age of the case 192 
cohort was 29.2 years (SD 9.68) and 23 435 (22.5%) were performed in female patients (Table 1). 193 
The majority of patients had no record of comorbidities (modified Charlson index zero; 90.65%), 194 
were of white ethnicity (75.62%), and from urban regions (79.97%) (Table 1). For five-year follow-195 
up ipsilateral ACL and meniscal surgery and contralateral ACL reconstruction, data was available 196 
for 54,275 procedures (Table 2). 197 
 198 
Figure 1: Case selection 199 
 200 
 201 
 202 
 203 
 204 
 205 
 206 
 207 
 208 
 209 
 210 
 211 
 212 
 213 
 214 
Excluded (concurrent procedures*) 
• Chondral surgery: 6345 
• Multi-ligament: 1845 
• Other*: 310 
104 255 ACLr 
(102 309 patients) 
133 270 ACLr 
(124 489 patients) 
Missing side: 3978 
Simultaneous bilateral: 1596 
Staged bilateral (<6 months): 313 
Revision procedures: 5209 
Less than 90 days follow up: 2815 
Repair or synthetic graft: 6690 
124 856 ACLr 
(117 104 patients) 
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* Same side or contralateral surgical procedures (not mutually exclusive). Other procedures included knee arthroplasty, fusion, 215 
interposition. 216 
 217 
TABLE 1: Demographics 218 
 219 
 n % 
All procedures 
Total 104 255 100% 
Sex 
Male 80820 77.52% (77.27, 77.77) 
Female 23435 22.48% (22.23, 22.73) 
Age group (years) 
<20 15357 14.73% (14.52, 14.95) 
20-39 72331 69.38% (69.10, 69.66) 
40-59 16069 15.41% (15.19, 15.63) 
60-79 475 0.46% (0.42, 0.50) 
80+ 23 0.02% (0.01, 0.03) 
Charlson index 
0 94503 90.65% (90.47, 90.82) 
1 - 15 9711 9.31% (9.14, 9.49) 
16 - 30 39 0.04% (0.03, 0.05) 
31 - 50 2 0.00% (0.00, 0.01) 
IMD 
1 21761 20.87% (20.63, 21.12) 
2 20853 20.00% (19.76, 20.25) 
3 20902 20.05% (19.81, 20.29) 
4 20173 19.35% (19.11, 19.59) 
5 18860 18.09% (17.86, 18.33) 
Missing 1706  
Rurality 
Urban 83376 79.97% (79.73, 80.22) 
Rural 20064 19.25% (19.01, 19.49) 
Missing 815  
Ethnicity 
White 78839 75.62% (75.36, 75.88) 
Asian 4658 4.47% (4.34, 4.60) 
Black 2025 1.94% (1.86, 2.03) 
Mixed 1245 1.19% (1.13, 1.26) 
Other 1821 1.75% (1.67, 1.83) 
Missing 15667  
 220 
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The rates of adverse medical and surgical outcomes within 90-days, and ligamentous or meniscal 221 
reoperation within 5-years, are summarised in Table 2. Overall, 0.97% underwent any reoperation 222 
with 90-days (1013/104255; 95% CI 0.91 to 1.03) and 0.65% developed a serious complication 223 
(675/104255; 95% CI 0.60 to 0.70) including a rate of 0.47% reoperations for presumed deep 224 
infection (494/104255; 95% CI 0.43 to 0.52). The rate of pulmonary embolism was 0.12% 225 
(129/104255; 95% CI 0.10 to 0.15), of neurovascular injury was 0.02% (19/104255; 95% CI 0.01 to 226 
0.03), and of fasciotomy was 0.02% (17/104255; 95% CI 0.01 to 0.03). Within 5-years, 3.22% 227 
(1746/54275; 95% CI 3.07 to 3.37) underwent a revision ACL reconstruction in the same knee, 228 
2.86% (1553/54275; 95% CI 2.72 to 3.01) underwent ACL reconstruction to the opposite knee, and 229 
0.63% (340/54275; 95% CI 0.56 to 0.70) underwent subsequent meniscal surgery in the same knee. 230 
The longer-term rates of revision ACL reconstruction are summarised in the mortality adjusted 231 
Kaplan-Meier chart, Figure 2, estimating revision rates out to 15-years by age group. Younger 232 
patients were at greater risk of revision as shown (Figure 2, Table 4).  233 
 234 
TABLE 2: Adverse outcomes within 90-days and reoperation rates within 5-years 235 
 
n % (95% CI) 
90-day adverse outcomes (n=104 255) 
Any re-operation‡ 1013 0.97% (0.91, 1.03) 
Serious complication † 675 0.65% (0.60, 0.70) 
Infection* 494 0.47% (0.43, 0.52) 
Lower respiratory tract infection 102 0.10% (0.08, 0.12) 
Urinary tract infection 44 0.04% (0.03, 0.06) 
Pulmonary embolism 129 0.12% (0.10, 0.15) 
Myocardial infarction 4 < 0.01% (0.00, 0.01) 
Mortality 14 0.01% (0.01, 0.02) 
Stroke 2 < 0.01% (0.00, 0.01) 
Acute kidney injury 13 0.01% (0.01, 0.02) 
Neurovascular injury 19 0.02% (0.01, 0.03) 
Fasciotomy 17 0.02% (0.01, 0.03) 
Fatal pulmonary embolus 0 0.00% (0.00, 0.00) 
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5-year reoperation (n = 54 275) 
Revision ACLr 1746 3.22% (3.07, 3.37) 
Subsequent contralateral ACLr 1553 2.86% (2.72, 3.01) 
Meniscal surgery 340 0.63% (0.56, 0.70) 
 236 
† = At least one serious complication within 90 days, defined as either pulmonary embolism, myocardial infarction, stroke, infection 237 
requiring surgery, fasciotomy, neurovascular injury, or death; * = Infection requiring surgery (open or arthroscopic lavage and 238 
irrigation or debridement of wound or joint); ‡ = Any procedure performed in the same knee (e.g. washout, meniscal repair, repeat 239 
meniscectomy, chondroplasty, ligamentous surgery, fasciotomy); ACLr = ACL reconstruction 240 
 241 
Figure 2: Long-term survival curve (not undergoing subsequent revision ACL reconstruction) 242 
 243 
* Age groups < 20 years and > 59 years suppressed due to small numbers 244 
 245 
Patient factors associated with adverse outcomes within 90-days are summarised in Table 3. Female 246 
patients were at lower odds of serious complications and infection; the overall odds of serious 247 
complications and of infection fell slightly over time (Table 3). Older age groups (under 20-years vs. 248 
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20-39-years vs. 40-59-years) were at greater risk of serious complications and pulmonary embolism 249 
as were patients with a greater modified Charlson comorbidity index (Table 3). Index of multiple 250 
deprivation and rurality did not affect the odds of complications. Patients of black ethnicity were 251 
found to be at greater odds of serious complications (adjusted OR 1.61; 95% CI 1.03 to 2.52) mainly 252 
due to greater odds of infection in comparison to patients in White ethnicity groups (adjusted OR 253 
1.88; 95% CI 1.16 to 3.05). The adjusted odds of serious complications by each patient factor 254 
(including patient age) is shown graphically in the forest plot, Figure 3. 255 
 256 
TABLE 3: Unadjusted and adjusted odds‡ of serious complication, pulmonary embolism, infection 257 
 258 
 
Serious complication † 
(90 days) 
Pulmonary embolism 
(90 days) 
Infection* 
(90 days) 
 
Crude OR 
(95% CI) 
Adjusted OR 
(95% CI) 
Crude OR 
(95% CI) 
Adjusted OR 
(95% CI) 
Crude OR 
(95% CI) 
Adjusted OR 
(95% CI) 
Sex 
Male 1.00 1.00 1.00 1.00 1.00 1.00 
Female 0.63 (0.51, 0.77) 0.61 (0.49, 0.77) 0.96 (0.63, 1.45) 0.91 (0.58, 1.41) 0.49 (0.38, 0.64) 0.48 (0.36, 0.65) 
Age group 
<20 0.61 (0.47, 0.79) 0.60 (0.45, 0.80) 0.35 (0.15, 0.81) 0.42 (0.18, 0.98) 0.65 (0.48, 0.87) 0.64 (0.47, 0.88) 
20-39 1.00 1.00 1.00 1.00 1.00 1.00 
40-59 1.20 (0.98, 1.46) 1.26 (1.02, 1.56) 2.25 (1.54, 3.30) 2.50 (1.66, 3.76) 0.88 (0.68, 1.13) 0.90 (0.68, 1.18) 
60-79 2.25 (1.06, 4.77) 1.94 (0.84, 4.45) 5.74 (1.81, 18.24) 5.32 (1.58, 17.93) 0.82 (0.20, 3.32) 0.45 (0.06, 3.22) 
80+ 6.83 (0.92, 50.79) 7.63 (1.01, 57.56) - - - - 
Year 
Per year 0.98 (0.96, 0.99) 0.96 (0.95, 0.98) 0.97 (0.94, 1.01) 0.97 (0.93, 1.01) 0.98 (0.96, 1.00) 0.97 (0.94, 0.99) 
Modified Charlson comorbidity index 
Per unit 1.11 (1.07, 1.14) 1.10 (1.05, 1.14) 1.16 (1.10, 1.23) 1.11 (1.04, 1.19) 1.07 (1.02, 1.12) 1.08 (1.03, 1.14) 
Index of multiple deprivation (quintile) 
1 = least 1.00 1.00 1.00 1.00 1.00 1.00 
2 1.08 (0.86, 1.36) 1.05 (0.82, 1.34) 0.73 (0.43, 1.24) 0.62 (0.35, 1.09) 1.16 (0.88, 1.52) 1.18 (0.89, 1.58) 
3 0.95 (0.75, 1.21) 0.95 (0.74, 1.22) 0.79 (0.47, 1.33) 0.66 (0.37, 1.15) 0.99 (0.74, 1.31) 1.02 (0.76, 1.37) 
4 0.93 (0.73, 1.18) 0.83 (0.64, 1.09) 0.56 (0.31, 1.00) 0.48 (0.25, 0.90) 1.02 (0.77, 1.36) 0.91 (0.67, 1.24) 
5 = most 1.02 (0.80, 1.29) 0.98 (0.75, 1.27) 1.05 (0.64, 1.72) 1.06 (0.62, 1.78) 1.05 (0.79, 1.40) 0.97 (0.71, 1.32) 
Rurality 
Urban 1.00 1.00 1.00 1.00 1.00 1.00 
Rural 1.08 (0.89, 1.30) 1.06 (0.86, 1.31) 0.90 (0.57, 1.42) 0.90 (0.54, 1.49) 1.08 (0.86, 1.34) 1.06 (0.83, 1.36) 
Ethnicity 
White 1.00 1.00 1.00 1.00 1.00 1.00 
Asian 1.11 (0.79, 1.56) 1.13 (0.80, 1.60) 1.15 (0.53, 2.48) 1.18 (0.54, 2.56) 1.13 (0.76, 1.69) 1.13 (0.75, 1.69) 
Black 1.53 (0.99, 2.38) 1.61 (1.03, 2.52) 0.76 (0.19, 3.06) 0.75 (0.18, 3.09) 1.81 (1.13, 2.91) 1.88 (1.16, 3.05) 
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Mixed 0.35 (0.11, 1.10) 0.40 (0.13, 1.23) - - 0.49 (0.16, 1.52) 0.53 (0.17, 1.65) 
Other 1.13 (0.67, 1.93) 1.19 (0.70, 2.03) 1.26 (0.40, 3.98) 1.31 (0.41, 4.15) 1.23 (0.67, 2.24) 1.27 (0.69, 2.32) 
 259 
‡ = procedure level multi-variable logistic regression model including sex, age group, year, Charlson co-morbidity index, index of 260 
multiple deprivation, rurality, and ethnicity; OR = odds ratio; CI = confidence interval; † = At least one serious complication within 261 
90 days, defined as either pulmonary embolism, myocardial infarction, stroke, infection requiring surgery, fasciotomy, neurovascular 262 
injury, or death; * = open or arthroscopic irrigation and lavage or debridement; - = suppressed.  263 
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Figure 3: Forest plot of adjusted‡ odds of any serious complication within 90-days 264 
 265 
‡ = procedure level multi-variable logistic regression model including sex, age group, year, modified Charlson 266 
comorbidity index, index of multiple deprivation (quintile), rurality, and ethnicity 267 
 268 
The patient factors associated with the risk of revision ACL reconstruction, contralateral ACL 269 
reconstruction, and same side meniscal surgery is summarised in Table 4. Female patients were at 270 
lower risk of revision ACL reconstruction (adjusted hazard ratio [HR] 0.81; 95% CI 0.74 to 0.89) 271 
and subsequent meniscal surgery (adjusted HR 0.61; 95% CI 0.49 to 0.75), but not contralateral ACL 272 
reconstruction (adjusted HR 1.06; 95% CI 0.95 to 1.18; Table 4). Older age groups (under 20-years 273 
vs. 20-39-years vs. 40-59-years vs 60-79-years), patients from rural regions or greater deprivation, 274 
and patients of Asian and Black ethnicity were less likely to undergo revision ACL reconstruction 275 
(Table 4). Patients of Asian ethnicity were also of lower risk of meniscus surgery but increased risk 276 
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of contralateral ACL reconstruction (Table 4). All three outcomes were slightly more common over 277 
the duration of the study by year of treatment. Patients with a greater modified Charlson comorbidity 278 
index were slightly more likely to undergo revision ACL reconstruction (adjusted HR 1.03 per unit; 279 
95% CI 1.01 to 1.06) but not meniscal surgery (adjusted HR 0.99; 95% CI 0.93 to 1.05) or 280 
contralateral reconstruction (adjusted HR 0.99; 95% CI 0.96 to 1.03; Table 4). 281 
 282 
The rate of mortality was lower in the ACL reconstruction cohort than reported in the general 283 
population (risk ratio [RR] 0.09; 95% CI 0.05 to 0.14) (Table 5). For male patients (under the age of 284 
80 years) undergoing ACL reconstruction, the risk of myocardial infarction was lower than in the 285 
general population (RR 0.09; 95% CI 0.03 to 0.23). No myocardial infarction was identified for this 286 
age-group in a female patient after ACL reconstruction. The rate of stroke (under the age of 75 287 
years) was also lower in the ACL reconstruction cohort than the general population (RR 0.06; 95% 288 
CI 0.01 to 0.23). In comparison, the risk of pulmonary embolism (RR 20.60; 95% CI 15.68 to 27.06) 289 
and infection (RR 385.91; 95% CI 282.60 to 526.98) was elevated in comparison to general 290 
population data. These data correspond to an estimated number needed to harm of 850 (95% CI 720-291 
1039) for one pulmonary embolism and 213 (95% CI 195-233) for one knee joint infection. 292 
 293 
TABLE 4: Unadjusted and adjusted hazard ratios for subsequent ipsilateral revision reconstruction, 294 
contralateral ligament reconstruction, ipsilateral meniscal surgery 295 
 296 
 Revision ACLr Subsequent Contralateral ACLr Subsequent meniscal surgery 
 
Crude HR 
(95% CI) 
Adjusted HR  
(95% CI) 
Crude HR 
(95% CI) 
Adjusted HR  
(95% CI) 
Crude HR 
(95% CI) 
Adjusted HR  
(95% CI) 
Sex 
Male 1.00 1.00 1.00 1.00 1.00 1.00 
Female 0.79 (0.73, 0.87)  
0.81 (0.74, 0.89) 
 
1.05 (0.95, 1.15) 
 
1.06 (0.95, 1.18) 
 
0.62 (0.50, 0.76) 
 
0.61 (0.49, 0.75) 
 
Age group 
<20 1.78 (1.64, 1.93)  
1.75 (1.61, 1.91) 
 
2.28 (2.08, 2.51) 
 
2.12 (1.92, 2.35) 
 
2.22 (1.88, 2.61) 
 
2.11 (1.78, 2.50) 
 
20-39 1.00 1.00 1.00 1.00 1.00 1.00 
40-59 0.52 (0.46, 0.59) 0.51 (0.44, 0.58) 0.44 (0.37, 0.52) 0.42 (0.35, 0.51) 0.36 (0.26, 0.50) 0.34 (0.24, 0.48) 
60-79 0.23 (0.07, 0.70) 0.15 (0.04, 0.61) 0.23 (0.06, 0.93) 0.13 (0.02, 0.89) - - 
  17 
80+ - - - - - - 
Year 
Per year 1.03 (1.02, 1.04)  
1.01 (1.00, 1.02) 
 
1.07 (1.06, 1.09) 
 
1.06 (1.04, 1.07) 
 
1.14 (1.11, 1.17) 
 
1.12 (1.09, 1.15) 
 
Modified Charlson comorbidity index 
Per unit 1.03 (1.01, 1.05)  
1.03 (1.01, 1.06) 
 
1.00 (0.97, 1.04) 
 
0.99 (0.96, 1.03) 
 
1.01 (0.95, 1.07) 
 
0.99 (0.93, 1.05) 
 
Index of multiple deprivation (quintile) 
1 = least 1.00 1.00 1.00 1.00 1.00 1.00 
2 0.87 (0.78, 0.96) 0.88 (0.79, 0.97) 0.93 (0.82, 1.06) 0.95 (0.82, 1.09) 0.98 (0.79, 1.20) 0.94 (0.75, 1.16) 
3 0.79 (0.71, 0.88) 0.80 (0.72, 0.89) 1.01 (0.89, 1.15) 1.00 (0.87, 1.15) 0.82 (0.66, 1.03) 0.83 (0.66, 1.04) 
4 0.78 (0.70, 0.87) 0.74 (0.66, 0.82) 0.99 (0.87, 1.13) 0.96 (0.83, 1.11) 0.79 (0.63, 0.99) 0.75 (0.60, 0.95) 
5 = most 0.68 (0.61, 0.77) 0.64 (0.56, 0.72) 1.03 (0.91, 1.18) 0.96 (0.83, 1.11) 0.58 (0.45, 0.74) 0.52 (0.40, 0.69) 
Rurality 
Urban 1.00 1.00 1.00 1.00 1.00 1.00 
Rural 0.83 (0.75, 0.91)  
0.76 (0.69, 0.84) 
 
1.02 (0.92, 1.13) 
 
0.98 (0.87, 1.11) 
 
0.98 (0.81, 1.17) 
 
0.89 (0.73, 1.08) 
 
Ethnicity 
White 1.00 1.00 1.00 1.00 1.00 1.00 
Asian 0.75 (0.62, 0.90) 0.73 (0.61, 0.89) 1.34 (1.11, 1.61) 1.31 (1.09, 1.59) 0.59 (0.37, 0.91) 0.58 (0.37, 0.91) 
Black 0.72 (0.55, 0.95) 0.74 (0.56, 0.97) 1.05 (0.78, 1.42) 1.00 (0.74, 1.35) 0.69 (0.38, 1.25) 0.73 (0.40, 1.34) 
Mixed 1.15 (0.85, 1.55) 1.09 (0.81, 1.46) 1.26 (0.87, 1.84) 1.09 (0.75, 1.59) 1.17 (0.63, 2.19) 1.05 (0.56, 1.97) 
Other 0.48 (0.33, 0.69) 0.50 (0.34, 0.72) 1.04 (0.75, 1.45) 1.07 (0.77, 1.48) 0.46 (0.21, 1.03) 0.49 (0.22, 1.09) 
 297 
‡ = procedure level Cox proportional hazards model including sex, age group, year, Charlson co-morbidity index, index of multiple 298 
deprivation, rurality, and ethnicity. HR = hazard ratio; CI = confidence interval; ACLr = anterior cruciate ligament reconstruction; - 299 
= suppressed. 300 
 301 
 302 
  303 
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TABLE 5: 90-day adverse event rates in study cohort versus age and/or sex matched general population 304 
data 305 
 306 
 General population risk % (95% 
CI) [publication reference] 
Study cohort risk % (95% CI) Risk ratio (95% CI) 
Mortality 
Overall: 
Age < 20 years: 
Age 20 - 39 years: 
Age 40 - 59 years: 
Age 60 - 79 years: 
Age 80 + years: 
0.158% (0.157, 0.159) 10 * 
0.007% (0.007, 0.008) 10 * 
0.011% (0.011, 0.012) 10 * 
0.043% (0.042, 0.044) 10 * 
0.233% (0.230, 0.236) 10 * 
2.043% (2.026, 2.060) 10 * 
0.013% (0.007, 0.023) 
0.007% (0.000, 0.036) 
0.010% (0.004, 0.020) 
0.031% (0.010, 0.073) 
0.000% (0.000, 0.774) 
4.348% (0.110, 21.949) 
0.09 (0.05, 0.14) 
0.89 (0.12, 6.30) 
0.84 (0.40, 1.77) 
0.73 (0.30, 1.75) 
- 
2.08 (0.31, 14.18) 
Myocardial infarction 
Men (age < 80):  
Women (age < 80): 
0.058% (0.049, 0.067) 38 
0.028% (0.022, 0.035) 38 
0.005% (0.001, 0.013) 
0.000% (0.000, 0.016) 
0.09 (0.03, 0.23) 
- 
Pulmonary embolism 
Overall: 0.006% (0.005, 0.007) 36 0.124% (0.103, 0.147) 20.60 (15.68, 27.06) 
Stroke 
Age < 75 years: 0.034% (0.030, 0.039) 12 0.002% (0.000, 0.007) 0.06 (0.01, 0.23) 
Septic arthritis (native knee joint infection) 
Overall: 0.001% (0.001, 0.002) 17 ‡ 0.474% (0.433, 0.517) 385.91 (282.60, 526.98) 
 307 
- = suppressed;  308 
* = Office for National Statistics population level data for England (2016, excluding death due to cancer);  309 
‡ = excluding iatrogenic causes. 310 
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DISCUSSION 312 
 313 
Principal findings 314 
Our study of 104 255 procedures shows that serious adverse events occur rarely following ACL 315 
reconstruction and that the risk of serious complications has fallen slightly over time. Most medical 316 
adverse events occur less frequently following ACL reconstruction than in the general population 317 
which is likely a healthy-cohort observation, however there is an important attributable risk of a 318 
pulmonary embolism and infection. For every 850 ACL reconstructions performed, one pulmonary 319 
embolism and four knee infections could occur and be attributed to the procedure. Around 3.2% of 320 
patients undergo revision ACL reconstruction and 2.9% contralateral ACL reconstruction within 321 
five-years. These findings will be crucial to informing patients and clinicians when deciding whether 322 
to proceed with elective ACL reconstruction. The recognised benefits of the procedure can now be 323 
interpreted in the context of the associated potential risks. 324 
 325 
Comparison with previous studies 326 
Despite the number of ACL reconstruction procedures performed worldwide,2,5,26 the adverse 327 
outcomes attributable to undergoing the procedure have previously been poorly defined. Several 328 
studies have reported adverse events following “knee arthroscopy” but few have reported data 329 
specifically for ACL reconstruction in comparison to more commonly performed purely 330 
arthroscopic, procedures such as arthroscopic partial meniscectomy.4,13,21,22,24,32–34,37 In comparison, 331 
anterior cruciate ligament reconstruction is a more major intervention, associated with greater 332 
operative time and usually both open and arthroscopic incisions and techniques.31 333 
 334 
In our study, only pulmonary embolism and infection were found to occur at a greater rate than 335 
observed in comparative general population data. These findings are similar to those reported 336 
recently for a cohort of 699 965 arthroscopic partial meniscectomy procedures.1 In this 337 
meniscectomy cohort, serious complications occurred in 0.32% (95% CI 0.30 to 0.33) in comparison 338 
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to 0.65% (95% CI 0.60 to 0.70) following ACL reconstruction using the same definitions. This 339 
difference in the serious complication rate was driven in part by a higher reoperation rate for 340 
infection following ACL reconstruction at 0.47% (95% CI 0.43 to 0.52) in comparison to 0.14% 341 
(95% CI 0.13 to 0.14) following arthroscopic partial meniscectomy.1 The infection rate identified in 342 
our study was similar but statistically more precise with an estimated deep infection rate of 0.43% 343 
(58/13401; 95% CI 0.32 to 0.56) ACL reconstruction cases reported in a systematic review of level 2 344 
studies in 2017.4 It is, however, higher than a rate of 0.14% (7/4933; 95% CI 0.05 to 0.29) reported 345 
in a study of the American College of Surgeons National Surgical Quality Improvement Program 346 
(ACS NSQIP) database.9 With comparison to general population data, the estimated number needed 347 
to harm for infection was 213 for our ACL reconstruction cohort versus 749 for the arthroscopic 348 
partial meniscectomy cohort.1 349 
 350 
The rate of pulmonary embolism within 90-days was greater in our ACL reconstruction cohort at 351 
0.12% (95% CI 0.10 to 0.15) in comparison to 0.08% (95% CI 0.07 to 0.09) in the recent 352 
arthroscopic partial meniscectomy cohort.1 No cases of fatal pulmonary embolism were identified 353 
following ACL reconstruction. The pulmonary embolism rate was comparable but statistically much 354 
more precise than the estimated rate of pulmonary embolism reported in a systematic review of 355 
forty-seven ACL reconstruction studies published in 2016, which reported a mean pulmonary 356 
embolism rate of 0.14% but with wide confidence intervals (1/704; 95% CI 0.00 to 0.79).22 The rate 357 
is also the same as another 2016 study of 4933 patients reporting a PE rate of 0.12% within 30-days 358 
(6/4933).9 With comparison to general population data, the number needed to harm for pulmonary 359 
embolism was estimated to be 850 for ACL reconstruction in comparison to 1390 for arthroscopic 360 
partial meniscectomy.1  361 
 362 
Prescribing data is unavailable in this database and therefore the type and duration of any antibiotic 363 
or venous thromboembolic (VTE) prophylaxis given to the patients in this study is unknown and it is 364 
likely that local practice varied. Previous work suggested that while antibiotic prophylaxis is routine 365 
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in most countries, VTE prophylaxis rates vary from around 17% Norway, 51% in the United States, 366 
to 79% in Denmark.18,23 The findings in this study may support further investigation and 367 
consideration of routine VTE prophylaxis in this population. 368 
 369 
Other direct surgical complications such as neurovascular injury and fasciotomy could not be 370 
compared to general population data. Both neurovascular injury and fasciotomy procedures were 371 
identified rarely following ACL reconstruction, at 0.02% in both cases. It must be noted, however, 372 
that these rates are approximately 5-10 times greater than reported following arthroscopic partial 373 
meniscectomy.1 The greater risk of these complications, infection, and pulmonary embolism, 374 
associated with ACL reconstruction in comparison to arthroscopic partial meniscectomy is 375 
unsurprising given the more invasive nature of ACL reconstruction, with additional surgical 376 
incisions and more prolonged operative time.31  377 
 378 
Regarding reoperation rates, the largest previous study published in 2016 reported an ACL revision 379 
rate of 3.6% (587/16336; 95% CI 3.31 to 3.89), utilising US military health record data.32 Our study 380 
reports a very similar rate of revision at 3.22% and adds importantly to these data, reporting 381 
contralateral ACL reconstruction in 2.86% and same side meniscal surgery in 0.63% within five-382 
years. The risk of revision ACL reconstruction was considerably greater in younger age groups, 383 
although it unknown if this reflects differences in injury rates or differences in propensity to re-384 
operate following injury. 385 
 386 
It is interesting that the risk of revision ACL reconstruction in the same knee was similar to the risk 387 
of contralateral ACL reconstruction, which suggests that both the reconstructed ligament and the 388 
native opposite knee ligament are at comparable risk of rupture following an ACL reconstruction. A 389 
systematic review of nine studies and a smaller number of patients previously reported an ipsilateral 390 
graft re-rupture rate of 7.9% (211/2682) but a higher 12.5% (335/2682) risk of contralateral ACL 391 
injury.24 Rates of subsequent meniscal surgery after ACL injury have rarely been reported. Frobell 392 
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et. al. reported a 9.7% (6/62; 95% CI 3.6 to 19.9) following ACL reconstruction and up to 49.2% 393 
(29/59; 95% CI 35.9 to 62.5) following a non-operative treatment strategy. A much lower rate of 394 
subsequent meniscal surgery was observed in our population at 0.63% (95% CI 0.56 to 0.70) which 395 
may reflect higher thresholds for subsequent intervention or lower symptomatic injury rates. 396 
 397 
Our study found revision reconstruction rates to be lower in women. This finding is similar to a 398 
recent systematic review of smaller studies which reported lower rates of ipsilateral graft rupture in 399 
women.27 This review also found women had a higher rate of contralateral knee injury however in 400 
our study we found no difference in contralateral knee reconstruction rates in women versus men. 401 
Subsequent meniscal surgery rates were also lower in women than men. Our study provides clear 402 
reference data for reconstruction rates in men and women and further investigation into the 403 
physiological, anatomical, and biomechanical factors that underlie these differences is warranted, 404 
with specific focus on preventative interventions. These findings will be crucial to the education of 405 
patients following ACL injury and reconstruction and inform collaboration between patients, 406 
physiotherapists, and clinicians in optimising current and future rehabilitation strategies. 407 
 408 
Strengths and limitations 409 
Our study is strengthened by the inclusion of 104 255 ACL reconstruction cases over a twenty-year 410 
period, utilising data from the complete national health database for England, UK. To our 411 
knowledge, this is by far the largest reported series of ACL reconstruction cases and the largest to 412 
report adverse outcomes. Patients undergoing bilateral surgery (within 6 months), multiple ligament 413 
reconstruction, ACL repair, synthetic graft procedures, or articular cartilage surgery were excluded. 414 
Patients undergoing concurrent meniscal procedures were, however, included as these procedures 415 
were common (approximately 28%) and therefore including these cases makes the cohort more 416 
representative of normal practice. Our study is also the most comprehensive evaluation of adverse 417 
outcomes, including the broad range of surgical and medical complications that may occur and, 418 
where possible, risk has been compared to age-sex matched general population data. The comparison 419 
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to general population data is relative crude but together with adverse outcome data following 420 
arthroscopic partial meniscectomy extracted from the same database, provides for the first time an 421 
important estimate of the attributable risk associated with ACL reconstruction. 422 
 423 
HES data includes diagnosis and intervention data from admitted hospital care episodes in the 424 
national health service, England, and is collected routinely for hospital reimbursement, audit and 425 
research purposes. Although HES comprehensively records diagnosis and procedural data for 426 
patients admitted to hospital, there are some limitations. Although our data included a patient-427 
specific modified Charlson comorbidity index, there are some important patient specific factors such 428 
as body mass index and smoking status that are not recorded in HES and are likely to impact upon 429 
risk. Regarding the accuracy of data coding in the database, the Charlson comorbidity index as 430 
calculated from HES diagnosis fields and records of serious vascular complications have been 431 
validated against primary care data.8,40 Some patient variables such as ethnicity, however, may be 432 
less reliably coded. It is also important to note that the OPCS-4 codes used to identify ACL 433 
reconstruction procedures for our patient cohort will have captured some posterior cruciate ligament 434 
reconstruction procedures. This is inevitable given the nature of the codes used for this procedure but 435 
the proportion of the posterior cruciate ligament reconstruction procedures performed is very small 436 
in comparison to ACL reconstruction and therefore we believe these procedures are unlikely to have 437 
materially altered our findings.3 The first ACL reconstruction per patient, per knee, was considered 438 
the primary procedure and revision procedures identified as any subsequent ACL reconstruction. 439 
Any primary procedure undertaken prior to 1st April 1997, however, would be not be identified and 440 
therefore it is possible a small number of revision procedures could have been included in our cohort 441 
as no “revision” code is available. From HES data we are also unable to determine the impact from 442 
operative factors, such as reconstruction technique and choice of graft on outcome as these operative 443 
techniques are not recorded. 444 
 445 
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Diagnoses from primary care or the outpatient department are not available in the HES inpatient 446 
dataset unless these diagnoses were associated with a later hospital admission for care or surgery. 447 
This means, for example, that the reported revision ACL reconstruction and contralateral ACL 448 
reconstruction rates in our study will be lower than the true ACL injury rates in the population. 449 
Similarly, soft tissue infections managed non-operatively will not have been recorded. Another 450 
limitation of the HES database is that laboratory and radiological data is not recorded. Therefore, 451 
whilst cases of knee open or arthroscopic irrigation and lavage or debridement with an associated 452 
‘haemarthrosis’ diagnosis code were not recorded as infections, from the remaining lavage and 453 
debridement procedures we cannot distinguish procedures performed for a laboratory confirmed 454 
infection from those with a suspected infection. The clinical implications in each case may be quite 455 
different and an important limitation of this observational HES data. It must also be considered that 456 
some patients may have undergone their primary ACL reconstruction in the national health service 457 
but subsequent care in the private health sector. This is unlikely to have affected the record of 458 
adverse events within 90-days, as patients are highly likely to have returned to a national health 459 
hospital in these cases. In the longer term, however, some patients may have chosen to have revision 460 
ACL reconstruction or contralateral ACL reconstruction in the private health sector and would not be 461 
captured and this must be considered when interpreting our long-term reoperation data. Minor 462 
adverse outcomes that may have been managed in primary care would also not be captured. Our 463 
findings are, however, by far the most comprehensive to date regarding the true risk of serious 464 
complications associated with undergoing ACL reconstruction and, we believe, should be broadly 465 
generalisable to ACL reconstruction practice in developed countries, worldwide. 466 
 467 
Conclusion 468 
Whilst the risk of adverse events following ACL reconstruction is greater than following 469 
arthroscopic partial meniscectomy, the overall risk is still low and most medical complications 470 
(myocardial infarction, stroke, death) occur less frequently following ACL reconstruction than in the 471 
general population. Nevertheless, rare but serious complications including pulmonary embolism, 472 
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infection, fasciotomy and neurovascular injury may by provoked by undergoing ACL reconstruction. 473 
Same side and contralateral knee ACL reconstruction was performed in 3.2% and 2.9% of cases 474 
within 5-years of primary ACL reconstruction respectively. Our findings will be crucial to informing 475 
patients considering the relative risks and benefits of undergoing early ACL reconstruction in 476 
comparison to the emerging treatment strategy of rehabilitation and optional delayed ACL 477 
reconstruction. Further work is required to optimise not only the primary treatment selection but also 478 
strategies to reduce reinjury rates. 479 
  480 
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